Yahoo Web Search

Search results

1. • 

     Earnings call: SelectQuote sees growth in Medicare Advantage, raises outlook By Investing.com

     Investing.com· 11 hours ago

     SelectQuote, Inc. (SLQT) delivered a confident fiscal third-quarter earnings report, emphasizing...

2. • eHealth Inc (EHTH) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst ...

     GuruFocus.com via Yahoo Finance· 3 days ago

     Medicare Advantage enrollment grew by 9% year-over-year, and Medicare Supplement enrollments increased by 35%, demonstrating ...

3. • Q1 2024 eHealth Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 3 days ago

     Moving now to our Amplify carrier dedicated platform, which generated just over $7 million in revenue in Q1, we saw continued traction with existing carrier customers performing ...

4. • 

     Earnings call: Assertio Holdings reports growth and CEO search progress By Investing.com

     Investing.com· 4 days ago

     The company highlighted a significant 32% quarter-over-quarter growth in Rolvedon sales and the...

5. • 

     Earnings call: Oscar Health posts first profitable quarter in Q1 2024

     Investing.com· 4 days ago

     (NYSE: OSCR) has announced its first-ever profitable quarter, with a notable increase in revenue and...

6. • 

     One year after the end of the COVID-19 pandemic emergency, Oregon among top states keeping people...

     The World· 5 days ago

     With more than 90 percent of the state’s 1.5 million renewals complete, more than 4 out of 5...

7. • Q1 2024 Supernus Pharmaceuticals Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 2 days ago

     Income tax expense in the first quarter of 2024 was $119,000 as compared to an income tax benefit of $7.9 million for the same period in 2023. Gaap net ...

8. • Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue...

     Digital Journal· 1 day ago

     TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...